Title:
インターロイキン−１０融合タンパク質及びその使用
Document Type and Number:
Japanese Patent JP6985232
Kind Code:
B2
Abstract:
The present invention generally relates to fusion proteins of antibodies and interleukin-10 (IL-10). In addition, the present invention relates to polynucleotides encoding such fusion proteins, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the fusion proteins of the invention, and to methods of using them in the treatment of disease.
Inventors:
Duanner, Lydia Jasmine
Thomas Emmrich
Fisher, Jens
Hosse, Ralph
Messner, Eckhard
Umagna, Pablo
Shui, Taiken
Thomas Emmrich
Fisher, Jens
Hosse, Ralph
Messner, Eckhard
Umagna, Pablo
Shui, Taiken
Application Number:
JP2018190250A
Publication Date:
December 22, 2021
Filing Date:
October 05, 2018
Export Citation:
Assignee:
Roche Glicart Age
International Classes:
C12N15/62; A61K39/395; A61P1/04; A61P19/02; A61P29/00; C07K14/54; C07K16/18; C07K19/00; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/13; C12N15/24; C12N15/63; C12P21/02
Domestic Patent References:
| JP2011502137A | ||||
| JP2008505174A |
Foreign References:
| WO2010005389A1 |
Other References:
THE JOURNAL OF IMMUNOLOGY,米国,1997年05月01日,V158 N9,P4507-4513
HUMAN ANTIBODIES,NL,1997年01月01日,V8 N3,P106-118
IMMUNOLOGY LETTERS,NL,1993年12月01日,V39 N1,P91-99
HUMAN ANTIBODIES,NL,1997年01月01日,V8 N3,P106-118
IMMUNOLOGY LETTERS,NL,1993年12月01日,V39 N1,P91-99
Attorney, Agent or Firm:
Sonoda/Kobayashi Patent Business Corporation